(Q33401759)

English

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

multiple myeloma

1 reference

based on heuristic

inferred from title

13

object named as

Bart Barlogie

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

8

object named as

Sarah Waheed

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

object named as

Antje Hoering

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11

object named as

Frits Van Rhee

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Saad Z Usmani

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Christoph Heuck

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alan Mitchell

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jackie Szymonifka

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bijay Nair

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yazan Alsayed

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sajjad Haider

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alejandro Restrepo

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

John Crowley

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

11 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1761-1767

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

The molecular characterization and clinical management of multiple myeloma in the post-genome era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Clinical implication of centrosome amplification in plasma cell neoplasm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

21 June 2018

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

31 October 2018

Long-term prognostic significance of response in multiple myeloma after stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

31 October 2018

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

31 October 2018

Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

31 October 2018

'Light-chain escape-multiple myeloma'-an escape phenomenon from plateau phase: report of the largest patient series using LC-monitoring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

31 October 2018

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487453

31 October 2018

Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22689675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/22689675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of extramedullary disease at presentation on the outcome of myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22689675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P53deletion may drive the clinical evolution and treatment response in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22689675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2012.065698

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33401759&oldid=1733981247"